食管癌患者的预后极差,只有5%病人在罹病后5年仍能生存。1980年的世界文献复习表明,平均手术后死亡率仍高达29%。虽然近年来文献报告本病的手术后死亡率已降至10～15%,但可惜只有少数患者有机会作根治性手术切除,约2/3病人仅能行姑息治疗。食管癌切除的病人中,鳞癌的患者5年生存率为36%,但腺癌患者仅3%。1983年有报告用顺铂、长春新碱及博莱霉素三联化学治疗晚期食管鳞状上皮癌 The prognosis of patients with esophageal cancer is extremely poor, and only 5% of patients survive after 5 years of rickets. The review of the world literature in 1980 showed that the average mortality rate after surgery was still as high as 29%. Although in recent years, the literature has reported that the mortality rate after surgery has dropped to 10 to 15%, but unfortunately only a small number of patients have the opportunity to undergo radical surgical resection, about 2/3 of patients can only be palliative care. In patients with esophageal cancer resection, the 5-year survival rate for squamous cell carcinoma was 36%, but only 3% for adenocarcinoma patients. In 1983, triple therapy with cisplatin, vincristine, and bleomycin was reported to treat advanced esophageal squamous cell carcinoma